{"id":22120,"date":"2023-02-10T21:42:00","date_gmt":"2023-02-10T13:42:00","guid":{"rendered":"https:\/\/flcube.com\/?p=22120"},"modified":"2025-07-04T11:44:34","modified_gmt":"2025-07-04T03:44:34","slug":"haohai-bio-acquires-additional-stake-in-sznimo-for-ophthalmic-expansion","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=22120","title":{"rendered":"Haohai Bio Acquires Additional Stake in SZNIMO for Ophthalmic Expansion"},"content":{"rendered":"\n

China-based Shanghai Haohai Biological Technology Co. Ltd (HKG: 6826<\/a>, SHA: 688366<\/a><\/a>), a leading biomaterial firm focused on ophthalmology, medical aesthetics, wound care, orthopedics, and anti-adhesion and hemostasis, has announced the acquisition of a 20% stake in compatriot firm Shenzhen New Industries Material of Ophthalmology Co., Ltd (SZNIMO) for a consideration of RMB 140 million (USD 20.59 million). This strategic move further solidifies Haohai Bio’s position in the ophthalmic market.<\/p>\n\n\n\n

SZNIMO: Market Presence and Distribution<\/strong>
SZNIMO is engaged in the distribution of intraocular lenses, ophthalmic viscoelastic agents, sodium hyaluronate gel for glaucoma surgery, and other imported products in the Chinese mainland. It is the sole agent of Lenstec (Barbados) Inc., a main supplier of imported intraocular lens products in China. This acquisition will enhance Haohai Bio’s distribution network and product portfolio in the ophthalmic sector.<\/p>\n\n\n\n

Haohai Bio’s Market Position<\/strong>
Haohai Bio, having previously acquired a 60% stake in SZNIMO, now becomes one of the leading manufacturers of artificial lenses in China through this transaction. The company’s expanded ownership in SZNIMO will allow it to leverage SZNIMO’s market presence and distribution capabilities, further strengthening its position as a key player in the ophthalmic market.<\/a>-Fineline Info & Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

China-based Shanghai Haohai Biological Technology Co. Ltd (HKG: 6826, SHA: 688366), a leading biomaterial firm…<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[4199,1263,3220,44],"class_list":["post-22120","post","type-post","status-publish","format-standard","hentry","category-company","category-deals","tag-haohai-biological-technology","tag-hkg-6826","tag-new-industries-material-of-ophthalmology","tag-ophthalmology"],"yoast_head":"\nHaohai Bio Acquires Additional Stake in SZNIMO for Ophthalmic Expansion - Insight, China's Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"China-based Shanghai Haohai Biological Technology Co. Ltd (HKG: 6826), a leading biomaterial firm focused on ophthalmology, medical aesthetics, wound care, orthopedics, and anti-adhesion and hemostasis, has announced the acquisition of a 20% stake in compatriot firm Shenzhen New Industries Material of Ophthalmology Co., Ltd (SZNIMO) for a consideration of RMB 140 million (USD 20.59 million). This strategic move further solidifies Haohai Bio's position in the ophthalmic market.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=22120\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Haohai Bio Acquires Additional Stake in SZNIMO for Ophthalmic Expansion\" \/>\n<meta property=\"og:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=22120\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China's Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-10T13:42:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-04T03:44:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=22120#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=22120\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Haohai Bio Acquires Additional Stake in SZNIMO for Ophthalmic Expansion\",\"datePublished\":\"2023-02-10T13:42:00+00:00\",\"dateModified\":\"2025-07-04T03:44:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=22120\"},\"wordCount\":205,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"Haohai Biological Technology\",\"HKG: 6826\",\"New Industries Material of Ophthalmology\",\"Ophthalmology\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=22120#respond\"]}],\"copyrightYear\":\"2023\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=22120\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=22120\",\"name\":\"Haohai Bio Acquires Additional Stake in SZNIMO for Ophthalmic Expansion - Insight, China's Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2023-02-10T13:42:00+00:00\",\"dateModified\":\"2025-07-04T03:44:34+00:00\",\"description\":\"China-based Shanghai Haohai Biological Technology Co. Ltd (HKG: 6826), a leading biomaterial firm focused on ophthalmology, medical aesthetics, wound care, orthopedics, and anti-adhesion and hemostasis, has announced the acquisition of a 20% stake in compatriot firm Shenzhen New Industries Material of Ophthalmology Co., Ltd (SZNIMO) for a consideration of RMB 140 million (USD 20.59 million). This strategic move further solidifies Haohai Bio's position in the ophthalmic market.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=22120#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=22120\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=22120#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Haohai Bio Acquires Additional Stake in SZNIMO for Ophthalmic Expansion\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Haohai Bio Acquires Additional Stake in SZNIMO for Ophthalmic Expansion - Insight, China's Pharmaceutical Industry","description":"China-based Shanghai Haohai Biological Technology Co. Ltd (HKG: 6826), a leading biomaterial firm focused on ophthalmology, medical aesthetics, wound care, orthopedics, and anti-adhesion and hemostasis, has announced the acquisition of a 20% stake in compatriot firm Shenzhen New Industries Material of Ophthalmology Co., Ltd (SZNIMO) for a consideration of RMB 140 million (USD 20.59 million). This strategic move further solidifies Haohai Bio's position in the ophthalmic market.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=22120","og_locale":"en_US","og_type":"article","og_title":"Haohai Bio Acquires Additional Stake in SZNIMO for Ophthalmic Expansion","og_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","og_url":"https:\/\/flcube.com\/?p=22120","og_site_name":"Insight, China's Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2023-02-10T13:42:00+00:00","article_modified_time":"2025-07-04T03:44:34+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=22120#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=22120"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Haohai Bio Acquires Additional Stake in SZNIMO for Ophthalmic Expansion","datePublished":"2023-02-10T13:42:00+00:00","dateModified":"2025-07-04T03:44:34+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=22120"},"wordCount":205,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["Haohai Biological Technology","HKG: 6826","New Industries Material of Ophthalmology","Ophthalmology"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=22120#respond"]}],"copyrightYear":"2023","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=22120","url":"https:\/\/flcube.com\/?p=22120","name":"Haohai Bio Acquires Additional Stake in SZNIMO for Ophthalmic Expansion - Insight, China's Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2023-02-10T13:42:00+00:00","dateModified":"2025-07-04T03:44:34+00:00","description":"China-based Shanghai Haohai Biological Technology Co. Ltd (HKG: 6826), a leading biomaterial firm focused on ophthalmology, medical aesthetics, wound care, orthopedics, and anti-adhesion and hemostasis, has announced the acquisition of a 20% stake in compatriot firm Shenzhen New Industries Material of Ophthalmology Co., Ltd (SZNIMO) for a consideration of RMB 140 million (USD 20.59 million). This strategic move further solidifies Haohai Bio's position in the ophthalmic market.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=22120#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=22120"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=22120#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Haohai Bio Acquires Additional Stake in SZNIMO for Ophthalmic Expansion"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/22120","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=22120"}],"version-history":[{"count":2,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/22120\/revisions"}],"predecessor-version":[{"id":36646,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/22120\/revisions\/36646"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=22120"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=22120"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=22120"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}